BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12743994)

  • 1. Retinoids, retinoic acid receptors, and breast cancer.
    Paik J; Blaner WS; Sommer KM; Moe R; Swisshlem K
    Cancer Invest; 2003 Apr; 21(2):304-12. PubMed ID: 12743994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of retinoid receptors in the prevention and treatment of breast cancer.
    Yang LM; Tin-U C; Wu K; Brown P
    J Mammary Gland Biol Neoplasia; 1999 Oct; 4(4):377-88. PubMed ID: 10705921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoids as differentiating agents in oncology: a network of interactions with intracellular pathways as the basis for rational therapeutic combinations.
    Garattini E; Gianni M; Terao M
    Curr Pharm Des; 2007; 13(13):1375-400. PubMed ID: 17506722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoid, retinoic acid receptor beta and breast cancer.
    Yang Q; Sakurai T; Kakudo K
    Breast Cancer Res Treat; 2002 Nov; 76(2):167-73. PubMed ID: 12452454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoids: present role and future potential.
    Evans TR; Kaye SB
    Br J Cancer; 1999 Apr; 80(1-2):1-8. PubMed ID: 10389969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Retinoid metabolism and cancer].
    Parisotto M; Brodeur H; Bhat PV; Mader S
    Med Sci (Paris); 2006 Dec; 22(12):1101-6. PubMed ID: 17156733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential role for retinoic acid receptor-gamma in the inhibition of breast cancer cells by selective retinoids and interferons.
    Fanjul AN; Bouterfa H; Dawson M; Pfahl M
    Cancer Res; 1996 Apr; 56(7):1571-7. PubMed ID: 8603404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells.
    Schneider SM; Offterdinger M; Huber H; Grunt TW
    Cancer Res; 2000 Oct; 60(19):5479-87. PubMed ID: 11034091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069.
    Wu K; Kim HT; Rodriquez JL; Hilsenbeck SG; Mohsin SK; Xu XC; Lamph WW; Kuhn JG; Green JE; Brown PH
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):467-74. PubMed ID: 12010861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoids and rexinoids in cancer prevention: from laboratory to clinic.
    Uray IP; Dmitrovsky E; Brown PH
    Semin Oncol; 2016 Feb; 43(1):49-64. PubMed ID: 26970124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoid receptors.
    Davidovici BB; Tüzün Y; Wolf R
    Dermatol Clin; 2007 Oct; 25(4):525-30, viii. PubMed ID: 17903611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer progression in MCF10A series of cell lines is associated with alterations in retinoic acid and retinoid X receptors and with differential response to retinoids.
    Peng X; Yun D; Christov K
    Int J Oncol; 2004 Oct; 25(4):961-71. PubMed ID: 15375546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoids: potential in cancer prevention and therapy.
    Clarke N; Germain P; Altucci L; Gronemeyer H
    Expert Rev Mol Med; 2004 Nov; 6(25):1-23. PubMed ID: 15569396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoids, neoplasia and differentiation therapy.
    Lippman SM; Davies PJ
    Cancer Chemother Biol Response Modif; 1997; 17():349-62. PubMed ID: 9551220
    [No Abstract]   [Full Text] [Related]  

  • 15. Retinoids and breast cancer: from basic studies to the clinic and back again.
    Garattini E; Bolis M; Garattini SK; Fratelli M; Centritto F; Paroni G; Gianni' M; Zanetti A; Pagani A; Fisher JN; Zambelli A; Terao M
    Cancer Treat Rev; 2014 Jul; 40(6):739-49. PubMed ID: 24480385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor-selective retinoids inhibit the growth of normal and malignant breast cells by inducing G1 cell cycle blockade.
    Wu K; DuPré E; Kim H; Tin-U CK; Bissonnette RP; Lamph WW; Brown PH
    Breast Cancer Res Treat; 2006 Mar; 96(2):147-57. PubMed ID: 16273314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism of action of retinoids in a new therapeutic approach to acute promyelocytic leukemia].
    Cornic M; Guidez F; Delva L; Agadir A; Degos L; Chomienne C
    Bull Cancer; 1992; 79(7):697-704. PubMed ID: 1334741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The retinoid receptors.
    Pemrick SM; Lucas DA; Grippo JF
    Leukemia; 1994; 8 Suppl 3():S1-10. PubMed ID: 7808017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytodifferentiation by retinoids, a novel therapeutic option in oncology: rational combinations with other therapeutic agents.
    Garattini E; Gianni' M; Terao M
    Vitam Horm; 2007; 75():301-54. PubMed ID: 17368321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of retinoic acid receptor-gamma selectively binding retinoids alone and in combination with interferon-gamma in breast cancer cell lines.
    Widschwendter M; Daxenbichler G; Culig Z; Michel S; Zeimet AG; Mörtl MG; Widschwendter A; Marth C
    Int J Cancer; 1997 May; 71(3):497-504. PubMed ID: 9139890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.